|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.71 USD | +2.69% |
|
+11.20% | +54.84% |
| 11-19 | Progyny Insider Sold Shares Worth $543,227, According to a Recent SEC Filing | MT |
| 11-17 | Progyny Shares Rise After CEO Anevski Buys $1.9 Million Worth of Shares | MT |
| Capitalization | 2.3B 1.96B 1.83B 1.72B 3.17B 209B 3.47B 21.39B 8.3B 98.31B 8.64B 8.46B 359B | P/E ratio 2025 * |
40.6x | P/E ratio 2026 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise value | 2.17B 1.85B 1.73B 1.62B 2.99B 196B 3.27B 20.15B 7.82B 92.61B 8.14B 7.97B 338B | EV / Sales 2025 * |
1.7x | EV / Sales 2026 * | 1.43x |
| Free-Float |
76.13% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Progyny, Inc.
| 1 day | +2.69% | ||
| 1 week | +11.20% | ||
| Current month | +1.29% | ||
| 1 month | +9.38% | ||
| 3 months | +18.66% | ||
| 6 months | +27.01% | ||
| Current year | +54.84% |
| 1 week | 23.78 | 26.79 | |
| 1 month | 23.75 | 27.51 | |
| Current year | 17.01 | 27.51 | |
| 1 year | 13.86 | 27.51 | |
| 3 years | 13.39 | 44.95 | |
| 5 years | 13.39 | 68.32 | |
| 10 years | 13.29 | 68.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Anevski
CEO | Chief Executive Officer | 58 | 31/12/2021 |
Michael Sturmer
PSD | President | 48 | 31/12/2021 |
Mark Livingston
DFI | Director of Finance/CFO | 59 | 14/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
David Schlanger
CHM | Chairman | 65 | 31/12/2021 |
Norman Payson
BRD | Director/Board Member | 50 | 15/12/2016 |
Peter Anevski
BRD | Director/Board Member | 58 | 31/12/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.69% | +11.20% | +82.82% | -15.93% | 2.3B | ||
| +1.52% | +3.30% | -34.32% | -36.49% | 310B | ||
| -0.32% | +8.56% | -5.86% | -30.86% | 79.8B | ||
| +0.90% | +3.49% | -2.54% | -16.82% | 73.38B | ||
| +0.74% | +4.11% | -2.07% | -48.68% | 32.29B | ||
| +0.96% | +6.55% | -31.25% | -50.91% | 20.08B | ||
| +0.96% | +10.96% | -44.39% | -51.68% | 8.66B | ||
| -0.26% | -0.97% | +69.08% | +59.87% | 3.87B | ||
| -1.82% | +4.65% | -13.18% | +143.24% | 1.4B | ||
| -2.25% | -0.17% | -24.41% | - | 385M | ||
| Average | +0.31% | +5.17% | -0.61% | -5.36% | 53.18B | |
| Weighted average by Cap. | +1.06% | +4.42% | -22.43% | -33.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.28B 1.09B 1.02B 956M 1.76B 116B 1.92B 11.85B 4.6B 54.49B 4.79B 4.69B 199B | 1.4B 1.19B 1.11B 1.05B 1.93B 127B 2.1B 12.98B 5.04B 59.67B 5.24B 5.13B 218B |
| Net income | 58.84M 50.12M 46.82M 44.05M 81.1M 5.33B 88.6M 547M 212M 2.51B 221M 216M 9.17B | 84.61M 72.08M 67.33M 63.35M 117M 7.66B 127M 786M 305M 3.61B 317M 311M 13.18B |
| Net Debt | -134M -114M -106M -99.98M -184M -12.09B -201M -1.24B -481M -5.7B -501M -490M -20.8B | -304M -259M -242M -227M -419M -27.51B -457M -2.82B -1.09B -12.97B -1.14B -1.12B -47.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 26.71 $ | +2.69% | 1,590,139 |
| 11/12/25 | 26.01 $ | +3.34% | 1,214,189 |
| 10/12/25 | 25.17 $ | +1.82% | 1,372,354 |
| 09/12/25 | 24.72 $ | +0.08% | 999,252 |
| 08/12/25 | 24.70 $ | +2.83% | 1,255,514 |
Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PGNY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















